Lebanon, NH, United States of America

Matthew Salotto

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Hanover, NH (US) (2021)
  • Lebanon, NH (US) (2022)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Matthew Salotto

Introduction

Matthew Salotto is an accomplished inventor based in Lebanon, NH, with a remarkable portfolio that includes six patents. His work primarily focuses on the development of innovative therapies targeting TGFβ (Transforming Growth Factor Beta), a crucial protein involved in many biological processes and associated with various diseases.

Latest Patents

Salotto's latest patents reflect his dedication to advancing medical science and treatment options. Among them is a patent entitled "Methods of screening for high-affinity, isoform-selective TGFβ1 inhibitors," which discloses monoclonal antibodies and their antigen-binding fragments capable of selectively inhibiting TGFβ1 with significant potency. This innovation holds promise for therapeutic applications in conditions related to TGFβ1 activity.

Additionally, he holds a patent for "LTBP complex-specific inhibitors of TGFβ and uses thereof." This patent reveals inhibitors, including antibodies that selectively bind to complexes of LTBP1-TGFβ and/or LTBP3-TGFβ. It outlines methods that could further aid in the treatment of TGFβ-related disorders, such as fibrotic conditions, by inhibiting TGFβ activation.

Career Highlights

Matthew Salotto currently contributes his expertise to Scholar Rock, Inc., a company known for its commitment to groundbreaking treatments targeting protein signaling pathways. His role at the company underscores his status as a thought leader in the research field, particularly concerning TGFβ signaling and its associated disorders.

Collaborations

In his professional journey, Salotto has collaborated with talented colleagues including Thomas Schurpf and Justin W. Jackson. These partnerships have paved the way for innovative solutions and have enhanced the research output at Scholar Rock, Inc.

Conclusion

Matthew Salotto stands out in the realm of biomedical innovation, pushing the boundaries of therapeutic research with his patents. His contributions help address pressing medical challenges, making him a key figure in the quest for effective treatments for TGFβ-related conditions. His dedication to this field not only showcases his inventiveness but also highlights the collaborative spirit that drives significant advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…